Stocksigma LogoStocksigma Logo

SPARC Schedules Board Meeting on 2nd Nov'26 to Consider Q2 FY27 Results

Sun Pharma Advanced Research Company Ltd (SPARC) has scheduled a Board of Directors meeting for 2nd Nov'26 to consider and approve the unaudited standalone

SPARC Schedules Board Meeting on 2nd Nov'26 to Consider Q2 FY27 Results

Sun Pharma Advanced Research Company Ltd 路 Intimation 路 02 Nov 2026, 5:30 am

SPARC Schedules Board Meeting on 2nd Nov'26 to Consider Q2 FY27 Results Sun Pharma Advanced Research Company Ltd (SPARC) has scheduled a Board of Directors meeting for 2nd Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. In compliance with SEBI insider trading regulations, the trading window for dealing in company securities has been closed for designated persons starting 1st Oct'26 and will remain closed until 48 hours after the declaration and submission of the financial results to stock exchanges.

Original exchange filing (PDF)

More announcements from Sun Pharma Advanced Research Company Ltd

All Sun Pharma Advanced Research Company Ltd announcements